The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced today that the 2022 Heine H. Hansen Award is conferred on Fred R. Hirsch for his lifelong outstanding contribution to lung cancer research.
Hirsch’s career in lung cancer research spans more than 25 years and includes translational research, targeted therapies and early detection of lung cancer. His research has helped to identify and validate prognostic markers for lung cancer outcomes and biomarkers for personalised lung cancer therapies that illustrate how these therapies work and who is most likely to benefit from them.
Hirsh is currently Executive Director at the Center for Thoracic Oncology in The Tisch Cancer Institute (TCI) and the Joe Lowe and Louis Price Professor of Medicine at the Icahn School of Medicine at Mount Sinai, New York, US.
He will deliver his award lecture on Wednesday, 30 March 2022 at ELCC 2022.